Literature DB >> 16075923

Serum cortisol and cortisone levels in newborns with congenital adrenal hyperplasia before the start of therapy.

J Dötsch1, I Hohenberger, F G Riepe, W G Sippell, H G Dörr.   

Abstract

Sodium loss in infants with salt wasting (SW) congenital adrenal hyperplasia (CAH) does usually not occur within the first week of life. We hypothesized that sufficient mineralocorticoid activity might by temporarily maintained by still appropriate concentrations of cortisol. Plasma samples were obtained from 15 infants with SW-CAH before the onset of sodium loss, 17 patients with simple virilizing (SV)-CAH and 28 healthy infants under 14 days of age. Plasma aldosterone concentrations were significantly lower in SW-CAH infants than in SV-CAH patients and in healthy neonates. Plasma cortisol levels and cortisol/cortisone (F/E) ratios in SW-CAH patients were almost the same as in the SV-CAH and control group. While declining plasma aldosterone levels precede the onset of SW in CAH patients, plasma cortisol concentrations are kept normal in SW-CAH infants, temporarily maintaining sufficient mineralocorticoid activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075923     DOI: 10.1007/bf03347220

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia.

Authors:  E Schoof; M Girstl; W Frobenius; M Kirschbaum; H G Dörr; W Rascher; J Dötsch
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

2.  Evidence of cortisol deficiency at birth in infants with the respiratory distress syndrome.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1974-01       Impact factor: 5.958

Review 3.  Mineralocorticoids in congenital adrenal hyperplasia.

Authors:  E G Biglieri; C E Kater
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

4.  Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life.

Authors:  P M Stewart; C B Whorwood; J I Mason
Journal:  J Steroid Biochem Mol Biol       Date:  1995-12       Impact factor: 4.292

5.  Plasma aldosterone and 11-deoxycortisol in term neonates: a reevaluation.

Authors:  H G Dörr; W G Sippell; H T Versmold; F Bidlingmaier; D Knorr
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

6.  Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.

Authors:  M T Pham-Huu-Trung; M C Raux; M Gourmelen; M C Baron; F Girard
Journal:  Acta Endocrinol (Copenh)       Date:  1976-07

7.  Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase.

Authors:  A K Agarwal; F M Rogerson; T Mune; P C White
Journal:  Genomics       Date:  1995-09-01       Impact factor: 5.736

8.  11Beta-hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action.

Authors:  T Suzuki; H Sasano; S Suzuki; G Hirasawa; J Takeyama; Y Muramatsu; F Date; H Nagura; Z S Krozowski
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

9.  Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

Authors:  T Mune; F M Rogerson; H Nikkilä; A K Agarwal; P C White
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

10.  Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery.

Authors:  W G Sippell; H Becker; H T Versmold; F Bidlingmaier; D Knorr
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

View more
  1 in total

1.  Birth length and weight in congenital adrenal hyperplasia according to the different phenotypes.

Authors:  Antonio Balsamo; Malgorzata Wasniewska; Giuseppe Di Pasquale; Giuseppina Salzano; Federico Baronio; Sara Bombaci; Filippo De Luca
Journal:  Eur J Pediatr       Date:  2006-03-07       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.